Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Basel

About this trial

This study aims to explore the impact of Animal Assisted Therapy (AAT) on brain signal complexity in patients with minimally conscious state (MCS) by analyzing electroencephalogram (EEG) entropy. MCS patients typically exhibit reduced brain entropy compared to healthy individuals, indicating lower brain complexity. The study will assess whether AAT can enhance this complexity, which is crucial for understanding consciousness levels. Entropy, a measure of randomness in brain activity, will be used to evaluate AAT's effectiveness. In addition, electrocardiography (ECG), electrodermal activity (EDA) and behavioral measurements will also be collected.

Eligibility criteria

Qualifiers

Inpatients in one of the study sites

Acquired brain injury resulting from either traumatic or non-traumatic events

Diagnosis of MCS defined by CRS-R according to the Aspen criteria (Giacino, 2005)

Informed consent as documented by signature by the patient's legal representative

Disqualifiers

Phobia or allergies to any of the involved animals

Medical contraindications: acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes)

Radical changes in medication (decision made with responsible physician)

Trial design

Treatments tested in this trial

  • Animal Assisted Occupational Therapy

Treatment groups

26 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Basel

Lead sponsor

Rehab Basel

Collaborator